These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28587741)

  • 1. Plasma level of big endothelin-1 predicts the prognosis in patients with hypertrophic cardiomyopathy.
    Wang Y; Tang Y; Zou Y; Wang D; Zhu L; Tian T; Wang J; Bao J; Hui R; Kang L; Song L; Wang J
    Int J Cardiol; 2017 Sep; 243():283-289. PubMed ID: 28587741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations Between Multiple Circulating Biomarkers and the Presence of Atrial Fibrillation in Hypertrophic Cardiomyopathy with or Without Left Ventricular Outflow Tract Obstruction.
    Liu L; Wu L; Zheng L; Ding L; Chen G; Fan X; Yao Y
    Int Heart J; 2019 Mar; 60(2):327-335. PubMed ID: 30626765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma big endothelin-1 predicts new-onset atrial fibrillation after surgical septal myectomy in patients with hypertrophic cardiomyopathy.
    Song C; Wang S; Guo Y; Zheng X; Lu J; Fang X; Wang S; Huang X
    BMC Cardiovasc Disord; 2019 May; 19(1):122. PubMed ID: 31117937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
    Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.
    Weng Z; Yao J; Chan RH; He J; Yang X; Zhou Y; He Y
    JACC Cardiovasc Imaging; 2016 Dec; 9(12):1392-1402. PubMed ID: 27450876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Yamanaka S; Hirota T; Baba Y; Hayashi K; Iiyama T; Kumagai N; Tanioka K; Yamasaki N; Matsumura Y; Furuno T; Sugiura T; Doi YL
    J Am Coll Cardiol; 2013 Oct; 62(14):1252-1259. PubMed ID: 23623916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of baseline big endothelin-1 level with long-term prognosis among cardiac resynchronization therapy recipients.
    Yang S; Liu Z; Liu S; Ding L; Chen K; Hua W; Zhang S
    Clin Biochem; 2018 Sep; 59():25-30. PubMed ID: 29913121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Uric Acid as a Prognostic Marker in Patients With Hypertrophic Cardiomyopathy.
    Zhu L; Wang J; Wang Y; Jia L; Sun K; Wang H; Zou Y; Tian T; Liu Y; Zou J; Hui R; Yuan Z; Song L
    Can J Cardiol; 2015 Oct; 31(10):1252-8. PubMed ID: 26111667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Matrix Metalloproteinases as Quantitative Biomarkers for Myocardial Fibrosis and Sudden Cardiac Death Risk Stratification in Patients With Hypertrophic Cardiomyopathy.
    Münch J; Avanesov M; Bannas P; Säring D; Krämer E; Mearini G; Carrier L; Suling A; Lund G; Patten M
    J Card Fail; 2016 Oct; 22(10):845-50. PubMed ID: 27018569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between plasma big endothelin-1 levels at admission and long-term outcomes in patients with atrial fibrillation.
    Wu S; Yang YM; Zhu J; Ren JM; Wang J; Zhang H; Shao XH
    Atherosclerosis; 2018 May; 272():1-7. PubMed ID: 29529394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
    Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
    Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between P wave dispersion, atrial electromechanical delay, left atrial remodeling, and NT-proBNP levels, in patients with hypertrophic cardiomyopathy.
    Tuluce K; Ozerkan F; Yakar Tuluce S; Yavuzgil O; Gurgun C; Bilgin M; Kahya Eren N; Kocabas U; Nalbantgil S; Soydas Cinar C
    Cardiol J; 2015; 22(1):94-100. PubMed ID: 24671901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy.
    Fan P; Zhang Y; Lu YT; Yang KQ; Lu PP; Zhang QY; Luo F; Lin YH; Zhou XL; Tian T
    Heart; 2021 May; 107(10):836-841. PubMed ID: 33055147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
    Chan RH; Maron BJ; Olivotto I; Pencina MJ; Assenza GE; Haas T; Lesser JR; Gruner C; Crean AM; Rakowski H; Udelson JE; Rowin E; Lombardi M; Cecchi F; Tomberli B; Spirito P; Formisano F; Biagini E; Rapezzi C; De Cecco CN; Autore C; Cook EF; Hong SN; Gibson CM; Manning WJ; Appelbaum E; Maron MS
    Circulation; 2014 Aug; 130(6):484-95. PubMed ID: 25092278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.
    Olivotto I; Maron BJ; Tomberli B; Appelbaum E; Salton C; Haas TS; Gibson CM; Nistri S; Servettini E; Chan RH; Udelson JE; Lesser JR; Cecchi F; Manning WJ; Maron MS
    J Am Coll Cardiol; 2013 Jul; 62(5):449-57. PubMed ID: 23643593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT).
    Masson S; Latini R; Anand IS; Barlera S; Judd D; Salio M; Perticone F; Perini G; Tognoni G; Cohn JN;
    J Card Fail; 2006 Jun; 12(5):375-80. PubMed ID: 16762801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue Doppler imaging and prognosis in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.
    Kitaoka H; Kubo T; Hayashi K; Yamasaki N; Matsumura Y; Furuno T; Doi YL
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):544-9. PubMed ID: 23060455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognostic value of big endothelin-1 and its combination with late gadolinium enhancement in patients with idiopathic restrictive cardiomyopathy.
    Qu Y; Zhang D; Hu Y; Wang J; Tan H; Qin F; Liu Y
    Clin Chim Acta; 2024 Jul; 561():119755. PubMed ID: 38821338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early gadolinium enhancement in hypertrophic cardiomyopathy: a potential premature marker of myocardial damage.
    Pozo E; Viliani D; Aguirre N; Agudo-Quilez P; Olivera MJ; Caballero P; Jiménez-Borreguero LJ; Alfonso F
    Int J Cardiovasc Imaging; 2016 Nov; 32(11):1635-1643. PubMed ID: 27503551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.